B.Grimm Pharma Teams Up with Inter Mohosot To Boost Medicine Access In Cambodia
B.Grimm Pharma partners with Inter Mohosot to distribute essential medications in Cambodia by 2025.
Breaking News
Oct 22, 2024
Simantini Singh Deo

Thailand's B.Grimm Pharma, a leader in pharmaceuticals, nutraceuticals, and cosmeceuticals, has partnered with Cambodia’s Inter Mohosot Co., Ltd. for the exclusive distribution of its medicines. As part of B.Grimm’s Healthcare division, the company is known for offering comprehensive healthcare solutions across the pharmaceutical spectrum. Through this Sole Distribution Agreement, Inter Mohosot will distribute over 16 essential medicines covering areas like cardiovascular, central nervous system, and musculoskeletal treatments.
These medications will address conditions such as depression, epilepsy, hypertension, diabetes, and neuropathic pain, ensuring that Cambodian patients have greater access to high-quality treatments. Starting in January 2025, these medications will be available in public hospitals, private clinics, and pharmacies across Phnom Penh and nearby provinces, providing much-needed healthcare solutions to Cambodian communities.
B.Grimm Pharma and Inter Mohosot are joining forces to make quality medications widely available to patients in Cambodia. By leveraging their combined expertise, the partnership aims to deliver advanced healthcare solutions that enhance access to essential treatments in a timely and effective manner. With Cambodia's healthcare market poised for growth, both companies are in a strong position to meet the increasing local demands.
This collaboration is more than a business venture; it reflects a shared commitment to improving the lives of Cambodian people. B.Grimm Pharma, known for its innovation and top-tier manufacturing standards, is dedicated to ensuring that everyone has access to the necessary medicines and healthcare products to improve their overall well-being. Through this partnership, the companies seek to foster positive changes in the Cambodian healthcare landscape, driving better patient outcomes.
Mr. Kittisak Dumrongtananurak, Head of B.Grimm Pharma, mentioned, "With the growing demand for medi- cations in Cambodia, B.Grimm Pharma is ready to meet the needs for quality pharmaceuticals and healthcare products. We are pleased to partner with Inter Mohosot, a trusted company with deep in- sights into the pharmaceutical business in Cambodia. This collaboration will not only support our expansion in the Cambodian market but also align with our goal to enhance access to quality medications for a broader population beyond Thailand"
Mr. Borey Koy, CEO of Inter Mohosot Co. Ltd., expressed his excitement about the collaboration, "We are ex- cited to partner with B.Grimm Pharma to promote access to quality medications in Cambodia. Inter Mohosot will leverage its expertise and network to complement B.Grimm Pharma's long standing com- mitment to product quality, ultimately improving healthcare opportunities for Cambodian citizens."